165 related articles for article (PubMed ID: 34838392)
1. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
[TBL] [Abstract][Full Text] [Related]
2. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
[TBL] [Abstract][Full Text] [Related]
4. Individualized Laparoscopic Therapy for Portal Hypertension: A Preliminary Single Center Experience.
Bai DS; Yang KS; Jiang GQ; Qian JJ; Chen P; Jin SJ
J Laparoendosc Adv Surg Tech A; 2017 Feb; 27(2):121-127. PubMed ID: 27715476
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of hepatectomy or radiofrequency ablation associated with splenectomy for the treatment of hepatocellular carcinoma and esophagogastric variceal bleeding.
Ma JL; Li P; Jiang L; Wei HS
Asian J Surg; 2022 Aug; 45(8):1607-1609. PubMed ID: 35414458
[No Abstract] [Full Text] [Related]
6. Splenectomy and azygoportal disconnection decreases the risk of hepatocellular carcinoma for cirrhosis patients with portal hypertension bleeding: a 10-year retrospective follow-up study based on the inverse probability of treatment weighting method.
Gao TM; Zhou J; Xiang XX; Jin SJ; Qian JJ; Zhang C; Zhou BH; Tang H; Bai DS; Jiang GQ
J Gastroenterol; 2023 May; 58(5):503-512. PubMed ID: 36943530
[TBL] [Abstract][Full Text] [Related]
7. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
He W; Zeng Q; Zheng Y; Chen M; Shen J; Qiu J; Chen M; Zou R; Liao Y; Li Q; Wu X; Li B; Yuan Y
BMC Cancer; 2015 Apr; 15():263. PubMed ID: 25886495
[TBL] [Abstract][Full Text] [Related]
8. [Intra-operative evaluation of portal pressure and immediate results of surgical treatment of portal hypertension in schistosomotic patients submitted to esophagogastric devascularization with splenectomy].
Silva-Neto Wde B; Cavarzan A; Herman P
Arq Gastroenterol; 2004; 41(3):150-4. PubMed ID: 15678198
[TBL] [Abstract][Full Text] [Related]
9. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F
HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Study to Compare Selective Decongestive Devascularization and Gastrosplenic Shunt versus Splenectomy with Pericardial Devascularization for the Treatment of Patients with Esophagogastric Varices Due to Cirrhotic Portal Hypertension.
Bao H; He Q; Dai N; Ye R; Zhang Q
Med Sci Monit; 2017 Jun; 23():2788-2795. PubMed ID: 28594784
[TBL] [Abstract][Full Text] [Related]
11. Is hepatectomy feasible for hepatocellular carcinoma patients with clinically significant portal hypertension and beyond the Milan criteria?
Lu Z; Wei X; Tan L; Xiang B; Gong W
Eur J Surg Oncol; 2023 Nov; 49(11):107073. PubMed ID: 37748278
[TBL] [Abstract][Full Text] [Related]
12. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
Fang KC; Su CW; Chiou YY; Lee PC; Chiu NC; Liu CA; Chen PH; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
Eur Radiol; 2017 Jun; 27(6):2600-2609. PubMed ID: 27678133
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis.
Guo ZY; Hong Y; Tu B; Cheng Y; Wang XM
Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):358-365. PubMed ID: 35370090
[TBL] [Abstract][Full Text] [Related]
14. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
Wang X; Sun X; Lei Y; Pei J; Ma K; Feng K; Lau WY; Xia F
J Invest Surg; 2023 Dec; 36(1):1-7. PubMed ID: 36345736
[TBL] [Abstract][Full Text] [Related]
15. The decreased risk of hepatocellular carcinoma in hepatitis B virus-related cirrhotic portal hypertension patients after laparoscopic splenectomy and azygoportal disconnection.
Gao TM; Xiao KQ; Xiang XX; Jin SJ; Qian JJ; Zhang C; Zhou BH; Tang H; Bai DS; Jiang GQ
Surg Endosc; 2023 Nov; 37(11):8522-8531. PubMed ID: 37775601
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: a systematic review and meta-analysis.
Xiang ZQ; Wu YC; Qu XL; Luo DJ; Liang H; Ameer S; Long ZT; Dai XM; Zhu Z
World J Surg Oncol; 2024 Jan; 22(1):3. PubMed ID: 38166925
[TBL] [Abstract][Full Text] [Related]
17. PORTAL PRESSURE DECREASE AFTER ESOPHAGOGASTRIC DEVASCULARIZATION AND SPLENECTOMY IN SCHISTOSOMIASIS: LONG-TERM VARICES BEHAVIOR, REBLEEDING RATE, AND ROLE OF ENDOSCOPIC TREATMENT.
Silva Neto WBD; Tredicci TM; Coelho FF; Makdissi FF; Herman P
Arq Gastroenterol; 2018; 55(2):170-174. PubMed ID: 30043868
[TBL] [Abstract][Full Text] [Related]
18. [Effect of splenectomy on the risk of hepatocellular carcinoma development among patients with liver cirrhosis and portal hypertension: a multi-institutional cohort study].
Zhang XF; Liu Y; Li JH; Lei P; Zhang XY; Wan Z; Lei T; Zhang N; Wu XN; Long ZD; Li ZF; Wang B; Liu XM; Wu Z; Chen X; Wang JX; Yuan P; Li Y; Zhou J; Pawlik M; Lyu Y
Zhonghua Wai Ke Za Zhi; 2021 Oct; 59(10):821-828. PubMed ID: 34619907
[No Abstract] [Full Text] [Related]
19. Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.
Lim C; Osseis M; Lahat E; Doussot A; Sotirov D; Hemery F; Lantéri-Minet M; Feray C; Salloum C; Azoulay D
Surg Endosc; 2019 Mar; 33(3):811-820. PubMed ID: 30003350
[TBL] [Abstract][Full Text] [Related]
20. Esophagogastric devascularization without splenectomy in portal hypertension: safe and effective?
Ni YB; Gao PJ; Wang D; Li Z; Zhu JY
Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):276-80. PubMed ID: 26063028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
